Back to FMR LLC FMR LLC

DSGNDSGN
Showing 8 of 22 quarters

Position history for FMR LLCFMR LLC's holdings in DESIGN THERAPEUTICS INC

Yes. FMR holds 776,462 shares of DSGN (Design Therapeutics), worth $11.2M, as of its Q2 2026 13F filing. It reduced the position by 21,949 shares (-2.8%) from Q1 2026. FMR has held DSGN in every 13F on record since Q1 2021, 22 quarterly filings.

Current Value

$11.2M

Current Shares

776,462

Total Value Change

+$6.8M

Total Shares Change

-52,203

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
776,462
-2.8%
$11.2M0.0%$14.47
0
2026-Q1
Increased
798,411
+3.5%
$8.5M0.0%$10.00
28
2025-Q4
Increased
771,268
+4.1%
$7.2M0.0%$9.79
28
2025-Q3
Decreased
740,849
-22.1%
$5.6M0.0%$6.85
0
2025-Q2
Increased
951,198
+0.3%
$3.2M0.0%$3.57
26
2025-Q1
Decreased
948,050
-0.4%
$3.7M0.0%$4.21
0
2024-Q4
Increased
951,882
+14.9%
$5.9M0.0%$6.17
31
2024-Q3
Increased
828,665
+922.8%
$4.5M0.0%$5.33
43

Other major holders of DSGN: CITADEL ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used